BUY IPCA Laboratories Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·26 Oct · today
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·23 Oct · 3d ago
MACD below its signal line — bearish momentum
Technicals · macd·26 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Sahi Research26 Oct 2026 · ~2 weeks · target ₹2,045 · Active
- BUY — Rakesh Bansal26 Oct 2026 · Same day · target ₹2,030 · SL hit
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · ~1 year · target ₹2,250 · Active
- BUY — Kunal Saraogi23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities
- BUY Netweb Technologies India26 Oct 2026 · ~2 weeks · target ₹4,400 · Active
- BUY BSE26 Oct 2026 · ~2 weeks · target ₹3,500 · Active
- BUY Ratnaveer Precision Engineering26 Oct 2026 · ~2 weeks · target ₹358 · Active
- BUY HBL Engineering26 Oct 2026 · ~2 weeks · target ₹915 · Active
- SELL Nippon Life India Asset Management23 Oct 2026 · ~2 weeks · target ₹800 · Active

